Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Ross

Showing results (11-20 of 54) with videos related to

Pageof 6
Sort By:
JAMA|August 26, 2024
Patient Assistance Programs-A New Era of Law and PolicyC Joseph Ross Daval, Aaron S Kesselheim
G3 (Bethesda, Md.)|November 21, 2015
Mitochondrial-Nuclear Epistasis Impacts Fitness and Mitochondrial Physiology of Interpopulation Caenorhabditis briggsae HybridsChih-Chiun Chang, Joel Rodriguez, Joseph Ross
Journal of Health Politics, Policy and Law|October 6, 2023
Federal Enforcement of Pharmaceutical Fraud under the False Claims Act, 2006-2022Liam Bendicksen, Aaron S Kesselheim, C Joseph Ross Daval
Health Affairs (Project Hope)|May 2, 2022
Unwanted Advice? Frequency, Characteristics, And Outcomes Of Negative Advisory Committee Votes For FDA-Approved DrugsC Joseph Ross Daval, Ameet Sarpatwari, Aaron S Kesselheim
The New England Journal of Medicine|August 19, 2022
Improving the Use of FDA Advisory CommitteesC Joseph Ross Daval, Aaron S Kesselheim, Ameet Sarpatwari
JAMA Internal Medicine|September 19, 2022
Holding Pharmaceutical and Medical Device Executives Accountable as Responsible Corporate OfficersC Joseph Ross Daval, Jerry Avorn, Aaron S Kesselheim
JAMA|September 8, 2023
Protecting Medicare's Discretion to Say No to Unproven TherapiesC Joseph Ross Daval, Liam Bendicksen, Aaron S Kesselheim
Journal of Medical Imaging (Bellingham, Wash.)|July 10, 2015
Texture analysis of images using a two-dimensional fast time-frequency transformChun Hing Cheng, Pyari Mohan Pradhan, Joseph Ross Mitchell
The New England Journal of Medicine|March 13, 2023
Eroding Judicial Deference to the FDA - Consequences for Public HealthC Joseph Ross Daval, Liam Bendicksen, Aaron S Kesselheim
BMJ Evidence-Based Medicine|March 21, 2023
US Food and Drug Administration regulatory reviewer disagreements and postmarket safety actions among new therapeuticsAshley Eadie, Andrea MacGregor, Joshua Wallach, et al.
Pageof 6

Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
JAMA|August 26, 2024
Patient Assistance Programs-A New Era of Law and PolicyC Joseph Ross Daval, Aaron S Kesselheim
G3 (Bethesda, Md.)|November 21, 2015
Mitochondrial-Nuclear Epistasis Impacts Fitness and Mitochondrial Physiology of Interpopulation Caenorhabditis briggsae HybridsChih-Chiun Chang, Joel Rodriguez, Joseph Ross
Journal of Health Politics, Policy and Law|October 6, 2023
Federal Enforcement of Pharmaceutical Fraud under the False Claims Act, 2006-2022Liam Bendicksen, Aaron S Kesselheim, C Joseph Ross Daval
Health Affairs (Project Hope)|May 2, 2022
Unwanted Advice? Frequency, Characteristics, And Outcomes Of Negative Advisory Committee Votes For FDA-Approved DrugsC Joseph Ross Daval, Ameet Sarpatwari, Aaron S Kesselheim
The New England Journal of Medicine|August 19, 2022
Improving the Use of FDA Advisory CommitteesC Joseph Ross Daval, Aaron S Kesselheim, Ameet Sarpatwari
JAMA Internal Medicine|September 19, 2022
Holding Pharmaceutical and Medical Device Executives Accountable as Responsible Corporate OfficersC Joseph Ross Daval, Jerry Avorn, Aaron S Kesselheim
JAMA|September 8, 2023
Protecting Medicare's Discretion to Say No to Unproven TherapiesC Joseph Ross Daval, Liam Bendicksen, Aaron S Kesselheim
Journal of Medical Imaging (Bellingham, Wash.)|July 10, 2015
Texture analysis of images using a two-dimensional fast time-frequency transformChun Hing Cheng, Pyari Mohan Pradhan, Joseph Ross Mitchell
The New England Journal of Medicine|March 13, 2023
Eroding Judicial Deference to the FDA - Consequences for Public HealthC Joseph Ross Daval, Liam Bendicksen, Aaron S Kesselheim
BMJ Evidence-Based Medicine|March 21, 2023
US Food and Drug Administration regulatory reviewer disagreements and postmarket safety actions among new therapeuticsAshley Eadie, Andrea MacGregor, Joshua Wallach, et al.
Pageof 6